CR2 and neoplasm: Residual tumor at necroscopy in CD21-CAR recipients showed CD21 down-regulation in spleens (P = 0.0013 by unpaired t test) but not bone marrow (not significant by unpaired t test, P = 0.1085) compared with control mice (fig.